SYMBOL: CERE
Company: Cerevel Therapeutics Holdings, Inc.
Company: Cerevel Therapeutics Holdings, Inc.
SYMBOL
: CEREStage: 5. Merger Complete
Size: $1.927.198.304
Latest Price: $15,16
Previous close: $15,03
All time high price: $18,84
Volume: 0
Average volume: 251.362
FOLLOW SPAC
DISCOVER NEW FRIENDS
GET AHEAD OF THE GAME
Cerevel Therapeutics Holdings, Inc. is listed on the stock exchange with the ticker / Symbol CERE,
CERE SPAC all time high was $18,84 and the lowest price in the last 52 week was: ,
the current CERE stock price is $15,16. CERE has an overall market cap of: $1.927.198.304.
The latest volume was: 0.
CERE is currently in stage: 5. Merger Complete.
You can read all about CERE and it’s information about the SPAC, news, SEC filings and more on our special data platform.
Want to know more about CERE and Cerevel Therapeutics Holdings, Inc.? Join us today.
CERE SPAC all time high was $18,84 and the lowest price in the last 52 week was: ,
the current CERE stock price is $15,16. CERE has an overall market cap of: $1.927.198.304.
The latest volume was: 0.
CERE is currently in stage: 5. Merger Complete.
You can read all about CERE and it’s information about the SPAC, news, SEC filings and more on our special data platform.
Want to know more about CERE and Cerevel Therapeutics Holdings, Inc.? Join us today.
- Perceptive Advisors' SPAC ARYA Sciences Acquisition IV prices $130 million IPO – Nasdaq
- Parallel and Ceres Acquisition Corp. Announce Business Combination to Create a Publicly Traded US Cannabis Well-Being Company – PRNewswire
- Ceres Acquisition Corp. Commences Trading on OTCQX Market – Financial Post
- Perceptive Advisors' fourth SPAC ARYA Sciences Acquisition IV files for a $130 million IPO – Nasdaq
- Cerevel Therapeutics Hosts Inaugural Virtual R&D Event to Review Darigabat (CVL-865) and Provide Overview of Key Preclinical Programs – Yahoo Finance
- Uddhav Thackeray Maharashtra CM: Shiv Sena chief takes oath, PM Modi tweets congratulations – Economic Times
- Cerevel Therapeutics Announces Third Quarter 2020 Financial Results and Key Business Highlights – GlobeNewswire
- Cerevel Therapeutics Debuts as Publicly Traded Neuroscience Company – BioSpace
- Canadian SPACs: Rising From The Ashes – Seeking Alpha
- Here’s Why You Should Be Buying Pfizer Like Its Insiders – Forbes
- Cerevel Therapeutics' Business Combination Agreement with Arya Sciences – Global Legal Chronicle
- Pfizer Spinoff Cerevel Merges with Arya Sciences and Goes Public – BioSpace
- Pfizer spinoff Cerevel to raise $445M in merger with blank-check company – BioPharma Dive
- Perceptive Advisors-sponsored SPAC agrees to deal with Bain Capital-backed Cerevel Therapeutics – PE Hub
- Pfizer Biopharma JV To Go Public In $780M SPAC Union – Law360